|

Gadolinium-Based Contrast Agent (GBCA) Clinical Trials

1 actively recruiting trial across 1 location

Top Sponsors

  • Hyperfine1

Indications

  • Infection/Inflammatory Lesions1
  • Extra-axial Tumors1
  • Intra-axial Tumors1
  • Cancer1

Amherst, New York1 trial

Evaluation of Gadolinium Based Contrast Agents for Portable MR Imaging Systems

Dent Neurologic Institute

N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.